These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23712759)

  • 41. The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies.
    Willis LF; Kumar A; Jain T; Caffry I; Xu Y; Radford SE; Kapur N; Vásquez M; Brockwell DJ
    Eng Rep; 2020 May; 2(5):e12147. PubMed ID: 34901768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developability assessment during the selection of novel therapeutic antibodies.
    Jarasch A; Koll H; Regula JT; Bader M; Papadimitriou A; Kettenberger H
    J Pharm Sci; 2015 Jun; 104(6):1885-1898. PubMed ID: 25821140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
    Perchiacca JM; Lee CC; Tessier PM
    Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies.
    Banks DD; Latypov RF; Ketchem RR; Woodard J; Scavezze JL; Siska CC; Razinkov VI
    J Pharm Sci; 2012 Aug; 101(8):2720-32. PubMed ID: 22648863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of viruses using novel protein A wash buffers.
    Bolton GR; Selvitelli KR; Iliescu I; Cecchini DJ
    Biotechnol Prog; 2015; 31(2):406-13. PubMed ID: 25482293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation.
    Wang Y; Latypov RF; Lomakin A; Meyer JA; Kerwin BA; Vunnum S; Benedek GB
    Mol Pharm; 2014 May; 11(5):1391-402. PubMed ID: 24679215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancing the stability and solubility of the glucocorticoid receptor ligand-binding domain by high-throughput library screening.
    Seitz T; Thoma R; Schoch GA; Stihle M; Benz J; D'Arcy B; Wiget A; Ruf A; Hennig M; Sterner R
    J Mol Biol; 2010 Nov; 403(4):562-77. PubMed ID: 20850457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide.
    Kim W; Kim Y; Min J; Kim DJ; Chang YT; Hecht MH
    ACS Chem Biol; 2006 Aug; 1(7):461-9. PubMed ID: 17168524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput development of amphiphile self-assembly materials: fast-tracking synthesis, characterization, formulation, application, and understanding.
    Mulet X; Conn CE; Fong C; Kennedy DF; Moghaddam MJ; Drummond CJ
    Acc Chem Res; 2013 Jul; 46(7):1497-505. PubMed ID: 23427836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates.
    Jacobs SA; Wu SJ; Feng Y; Bethea D; O'Neil KT
    Pharm Res; 2010 Jan; 27(1):65-71. PubMed ID: 19911257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a screening platform for directed evolution using the reef coral fluorescent protein ZsGreen as a solubility reporter.
    Heddle C; Mazaleyrat SL
    Protein Eng Des Sel; 2007 Jul; 20(7):327-37. PubMed ID: 17584755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies.
    Samra HS; He F
    Mol Pharm; 2012 Apr; 9(4):696-707. PubMed ID: 22263524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.
    Razinkov VI; Treuheit MJ; Becker GW
    J Biomol Screen; 2015 Apr; 20(4):468-83. PubMed ID: 25576149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo and in vitro protein solubility assays using split GFP.
    Cabantous S; Waldo GS
    Nat Methods; 2006 Oct; 3(10):845-54. PubMed ID: 16990817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid and accurate in silico solubility screening of a monoclonal antibody library.
    Sormanni P; Amery L; Ekizoglou S; Vendruscolo M; Popovic B
    Sci Rep; 2017 Aug; 7(1):8200. PubMed ID: 28811609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.
    Fowler SB; Poon S; Muff R; Chiti F; Dobson CM; Zurdo J
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10105-10. PubMed ID: 16006528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nondenaturing size-exclusion chromatography-mass spectrometry to measure stress-induced aggregation in a complex mixture of monoclonal antibodies.
    Woodard J; Lau H; Latypov RF
    Anal Chem; 2013 Jul; 85(13):6429-36. PubMed ID: 23742703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characterization and analysis of the aggregation of a single-chain chimeric anti-ErbB2 antibody].
    Zhu J; Rong Z; Jiang B; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1918-23. PubMed ID: 19256339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates.
    Sule SV; Dickinson CD; Lu J; Chow CK; Tessier PM
    Mol Pharm; 2013 Apr; 10(4):1322-31. PubMed ID: 23383873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the Aggregation Propensity of Single-Domain Antibodies upon Heat-Denaturation Employing the ΔT
    Kunz P
    Methods Mol Biol; 2022; 2446():233-244. PubMed ID: 35157276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.